Page 160 - Read Online
P. 160

According to Suleiman classification, in order to help   must be taken for autoantibody testing, and a Ig total
            in the diagnosis 5 different autoimmune epilepsy   level as well as a study of lymphocytic profile should
            categories are identifiable, on the basis both of the   be performed, in order to get a value to compare later
            data  obtained  and  of  the  immunotherapy  response.   on with [Figure 2].
            Treatment may lead to remission, but the response
            depends on the specific form and possible association   If NSAbs are detected, the diagnosis is usually easily
            with malignancy. [7,45]  In some forms, such as NMDA-R   achieved. On a practical level, the expanding NSAbs
            encephalitis, a complete recovery occurs in  about   spectrum could make it difficult to choose which
            80% with a very low mortality rate. [13,14,46-48]  When a   antibody to check first. In order to direct the diagnostic
            complete remission does not occur, sequelae ranging   pathway, indirect immunohistochemistry on rat
            from drug-resistant epilepsy associated with cognitive   brain tissue or immunocytochemistry in primary
            decline, to milder cognitive impairment are easily   rat neuronal culture can highlight staining patterns
            detectable. [1,12,13,47]                          evocative for surface (e.g. neuropil) or intracellular
                                                              antigens.
            Following the treatment phase, EEG interictal activities
            slowly improve and longitudinal MRI studies can   This preliminary screening must be confirmed by more
            reveal a trend toward complete resolution, especially in   specific tecniques, such as cell-based assay, ELISA or
                                                                               [51]
            some specific NSAS and when a rapid immunotherapy   radioimmunoassay.  A blended approach reduces the
                                                                              [52]
            is administered. A more severe course towards a   false positive rate,  providing an efficient diagnostic
            global atrophy predominantly affecting hippocampus,   tool for pediatric NSAS.
            frontal and parietal regions usually characterizes the
            remaining cases.  An EEG monitoring including     A paraneoplastic cause is much less probable in
                           [43]
            awakeness and sleep recordings (e.g. 40 min cad) as   children, so that testing for onconeural antibodies (Hu,
            well as a neuroradiological surveillance are thereby   Ma2, CV2/CRMP5, Ri, amphiphysin) can be not strictly
            suggested.                                        necessary, at first instance at least. Nevertheless, if a
                                                              paraneoplastic clinical picture shows-up, a commercial
            Ideally,  CSF  and  autoimmune  responses  should  be   immunoblotting assay specifically designed can be
            investigated as soon as there is suspicion of autoimmune   properly used to manage a differential diagnosis.
            encephalitis.
                                                              TUMOR SURVEILLANCE
            CSF FINDINGS
                                                              Because of the low prevalence of malignancy in
            As in adult, CSF usually shows a mild to moderate   pediatric NSAS, many authors consider tumor
            lymphocytic pleocytosis (< 100 white blood cells/μL),   surveillance not strictly necessary in the first
            increased protein concentration (< 150 mg/dL), normal   instance, with the only exception related to NMDA-R
            glucose level and frequently elevated IgG index;   encephalitis. Nevertheless it may become increasingly
            oligoclonal  bands  result  detectable  in  about  50%  of   relevant in patients who are older at the time of clinical
            cases.                                            onset. [13]

            In children, elevated CSF neopterin can be used as an   TREATMENT
            additional marker of CNS inflammation. [10,49]
                                                              Due to antibodies pathogenicity, treatment is focused
            A recent study underlies the role of the CXCL13   on reducing the serum antibodies titer. There is no
            chemokine as a potential CSF biomarker of clinical   consensus on the immunotherapy approach to carry
            outcome in anti-NMDAR encephalitis, its prolonged or   out, but it has become increasingly clear that starting
            secondary elevation suggesting a limited response to   treatment as early as possible is crucial to achieve a
            immunotherapy, an higher risk of relapses, and thereby   better clinical outcome. [12,48]
            the need to a more aggressive therapeutic approach. [50]
                                                              At seizure onset, antiepileptic therapy, with few
            IMMUNOLOGICAL FINDINGS                            exceptions, usually results ineffective. [9]

            As soon as an autoimmune condition is suspected   During the acute phase, as the diagnostic work out
            (at prodromal or early acute stage) and before    may take time, starting immunotherapy empirically
            immunotherapy is started, a serum and/or CSF sample   is highly recommended. Although some patients
            Neuroimmunol Neuroinflammation | Volume 3 | July 8, 2016                                      151
   155   156   157   158   159   160   161   162   163   164   165